150 related articles for article (PubMed ID: 38072401)
41. Prognostic determinants in patients with uterine and ovarian carcinosarcoma.
Rauh-Hain JA; Shoni M; Schorge JO; Goodman A; Horowitz NS; del Carmen MG
J Reprod Med; 2013; 58(7-8):297-304. PubMed ID: 23947079
[TBL] [Abstract][Full Text] [Related]
42. Epidemiology and prediction model of patients with carcinosarcoma in the United States.
Chen M; He X; Yang Q; Zhang J; Peng J; Wang D; Tong K; Huang W
Front Public Health; 2022; 10():1038211. PubMed ID: 36518582
[TBL] [Abstract][Full Text] [Related]
43. Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity.
Matsuzaki S; Klar M; Matsuzaki S; Roman LD; Sood AK; Matsuo K
Gynecol Oncol; 2021 Feb; 160(2):586-601. PubMed ID: 33183764
[TBL] [Abstract][Full Text] [Related]
44. Changes in ovarian cancer survival during the 20 years before the era of targeted therapy.
Lee JY; Kim S; Kim YT; Lim MC; Lee B; Jung KW; Kim JW; Park SY; Won YJ
BMC Cancer; 2018 May; 18(1):601. PubMed ID: 29843633
[TBL] [Abstract][Full Text] [Related]
45. Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: a Korean gynecologic oncology group study (OV 1708).
Chung YS; Park SY; Lee JY; Park JY; Lee JW; Kim HS; Suh DS; Kim YH; Lee JM; Kim M; Choi MC; Shim SH; Lee KH; Song T; Hong JH; Lee WM; Lee B; Lee IH
BMC Cancer; 2019 Apr; 19(1):341. PubMed ID: 30971221
[TBL] [Abstract][Full Text] [Related]
46. A Nationwide, Population-Based Epidemiologic Study of Childhood Brain Tumors in Korea, 2005-2014: A Comparison with United States Data.
Kang JM; Ha J; Hong EK; Ju HY; Park BK; Shin SH; Won YJ; Jung KW; Park HJ
Cancer Epidemiol Biomarkers Prev; 2019 Feb; 28(2):409-416. PubMed ID: 30348678
[TBL] [Abstract][Full Text] [Related]
47. Clinical outcomes and patterns of care in the treatment of carcinosarcoma of the breast.
Kennedy WR; Gabani P; Acharya S; Thomas MA; Zoberi I
Cancer Med; 2019 Apr; 8(4):1379-1388. PubMed ID: 30864198
[TBL] [Abstract][Full Text] [Related]
48. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
49. Gynecological carcinosarcomas: Overview and future perspectives.
Collet L; González López AM; Romeo C; Méeus P; Chopin N; Rossi L; Rowinski E; Serre AA; Rannou C; Buisson A; Treilleux I; Ray-Coquard I
Bull Cancer; 2023 Nov; 110(11):1215-1226. PubMed ID: 37679206
[TBL] [Abstract][Full Text] [Related]
50. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
Zhu J; Wen H; Bi R; Wu X
J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
[TBL] [Abstract][Full Text] [Related]
51. Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment.
Yalcin I; Meydanli MM; Turan AT; Taskin S; Sari ME; Gungor T; Akbayir O; Ayhan A
Int J Clin Oncol; 2018 Apr; 23(2):329-337. PubMed ID: 29143144
[TBL] [Abstract][Full Text] [Related]
52. Nationwide Population-Based Incidence and Survival Rates of Malignant Central Nervous System Germ Cell Tumors in Korea, 2005-2012.
Lee SH; Jung KW; Ha J; Oh CM; Kim H; Park HJ; Yoo H; Won YJ
Cancer Res Treat; 2017 Apr; 49(2):494-501. PubMed ID: 27554477
[TBL] [Abstract][Full Text] [Related]
53. Trends of human papillomavirus-related head and neck cancers in Korea: national cancer registry data.
Shin A; Jung YS; Jung KW; Kim K; Ryu J; Won YJ
Laryngoscope; 2013 Nov; 123(11):E30-7. PubMed ID: 23754527
[TBL] [Abstract][Full Text] [Related]
54. Recent Changes in the Incidence of Thyroid Cancer in Korea between 2005 and 2018: Analysis of Korean National Data.
Choi YM; Lee J; Kwak MK; Jeon MJ; Kim TY; Hong EG; Kim WB; Kim WG
Endocrinol Metab (Seoul); 2022 Oct; 37(5):791-799. PubMed ID: 36220137
[TBL] [Abstract][Full Text] [Related]
55. Uterine and ovary carcinosarcomas: outcome, prognosis factors, and adjuvant therapy.
Pacaut C; Bourmaud A; Rivoirard R; Moriceau G; Guy JB; Collard O; Bosacki C; Jacquin JP; Levy A; Chauleur C; Magné N; Merrouche Y
Am J Clin Oncol; 2015 Jun; 38(3):272-7. PubMed ID: 23751320
[TBL] [Abstract][Full Text] [Related]
56. Trends in the incidence of in situ and invasive cervical cancer by age group and histological type in Korea from 1993 to 2009.
Oh CM; Jung KW; Won YJ; Shin A; Kong HJ; Jun JK; Park SY
PLoS One; 2013; 8(8):e72012. PubMed ID: 23977194
[TBL] [Abstract][Full Text] [Related]
57. Incidence and Survival of Childhood Cancer in Korea.
Park HJ; Moon EK; Yoon JY; Oh CM; Jung KW; Park BK; Shin HY; Won YJ
Cancer Res Treat; 2016 Jul; 48(3):869-82. PubMed ID: 26790965
[TBL] [Abstract][Full Text] [Related]
58. Trends of Incidence and Survival Rates of Mucosa-associated Lymphoid Tissue Lymphoma in the Korean Population: Analysis of the Korea Central Cancer Registry Database.
Jeong SH; Hyun SY; Choi JS; Kim HM
J Korean Med Sci; 2020 Sep; 35(36):e294. PubMed ID: 32924338
[TBL] [Abstract][Full Text] [Related]
59. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
60. Trends in Gynecologic Carcinosarcoma Based on Analysis of the Surveillance Epidemiology End Result (SEER) Database.
Lee JW; Ouh YT; Chang HK; Min KJ; Lee S; Hong JH; Song JY; Lee JK; Lee NW
J Clin Med; 2023 Feb; 12(3):. PubMed ID: 36769835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
